#AXON TASER COST PDF#
#AXON TASER COST FULL#
#AXON TASER COST SOFTWARE#

And for the full year, adjusted EBITDA grew 43% to $88 million. In Q4, we more than tripled our adjusted EBITDA over last year. Excluding the impact of that, the results are pretty impressive. This did result in a significant catch-up stock compensation expense that affected GAAP net income. In Q4, six additional performance goals in our eXponential Stock Performance Plan for our employees became statistically probable in light of our strengthened future outlook. We're also very pleased with our bottom line performance. We're going to keep innovating on behalf of this historically underserved market and our top line performance demonstrates that our customers are savvy and eager to adopt the latest technology. We're absolutely thrilled that customers are selecting our most meaningful integrated bundles. Axon products provide real value to our customers and the communities they serve. It feels great to top $0.5 billion in revenue, but I'm even more focused on what this signifies. For the full year, we grew revenue 26% to $531 million. Q4 revenue of $172 million was up 50% year-over-year, reflecting record volume camera shipments.ДЄbout 75% of our body camera units shipped in Q4 were Axon Body 3. I told you in August that we had high expectations for Axon Body 3, and we're planning for meaningful shipments in Q4.

We also made significant investments in people and processes to improve future product launches. We introduced the industry's first body camera with live streaming, and we went live with Axon Records. In 2019, we scaled the all-new TASER 7, while implementing significant design improvements in the cartridges. We are emboldened as we look to the future from our strong base of execution, our team delivered, this past year. We will leverage the power of artificial intelligence to enhance public safety, but with oversight from our industry-leading AI ethics board to ensure we also cherish and preserve individual rights and privacy in the balance. And we've doubled down on our mission to make justice system more efficient, more transparent and more equitable. Before this decade is out, we will deliver a TASER weapon that will outperform a semiautomatic pistol in the effective and reliable incapacitation of a human subject.

2019 was the year we planted the flag for our moonshot, make the bullet obsolete with the publication of my book, The End of killing. I'm incredibly proud of everyone here at Axon for delivering another banner year with strong top and bottom line performance, while simultaneously executing on several major product launches. Thanks, Andrea, and thank you, everyone, for joining us today. Rick Smith - Chief Executive Officer and Founder I will now turn the call over to Rick Smith, our Chief Executive Officer. These risks are discussed in our SEC filings. All forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially.

These comments are based on our predictions and expectations as of today and are not guarantees of future performance. Any forward-looking statements made today are pursuant to and within the meaning of the safe harbor provision of the Private Securities Litigation Reform Act of 1995. Management's remarks today are meant to build upon the information in that letter.Дuring this call, we will discuss our business outlook and make forward-looking statements.

#AXON TASER COST PDF#

And for the first time, we published an ESG addendum, which you can find in the PDF linked on our website. I hope you've all had a chance to read our shareholder letter, which was released after the market closed.

#AXON TASER COST SOFTWARE#

And joining us from our Global Software Hub in Seattle is our Chief Product Officer, Jeff Kunins. Here in the room in Scottsdale headquarters, we have Axon's CEO, Rick Smith President, Luke Larson CFO, Jawad Ahsan and Chief Revenue Officer, Josh Isner. Welcome to Axon's Fourth Quarter 2019 Earnings Conference Webcast. Andrea Susan James - Vice President of Investor Relations

Axon taser cost